Disease overview Chronic lymphocytic leukemia (CLL) is one of the most frequent types of
leukemia. It typically occurs in elderly patients and has a highly variable clinical course …

Chimeric antigen receptor (CAR) T cell therapy, together with checkpoint inhibition, has
been celebrated as a breakthrough technology due to the substantial benefit observed in …

Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide
surveillance of cancer survival by central analysis of population-based registry data, as a …

Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal
centre (GC) B cell differentiation. FL represents~ 5% of all haematological neoplasms and …

Background Cancer survival is a key measure of the effectiveness of health-care systems.
EUROCARE—the largest cooperative study of population-based cancer survival in Europe …

Unprecedented advances in our understanding of the pathobiology, prognostication, and
therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years …

Diffuse large B-cell lymphoma (DLBCL) constitutes 30%–58% of non-Hodgkin's lymphoma
series. The crude incidence in Europe is 3.8/100 000/year [1]. The incidence increases with …

Background: Population-based information about cancer occurrence and survival are
required to inform clinical practice and research; but for most lymphomas data are lacking …

The estimated overall incidence of acute lymphoblastic leukaemia (ALL) and lymphoblastic
lymphoma in Europe is 1.28 per 100 000 individuals annually, with significant age-related …

Background: Ascertainment of cases and disease classification is an acknowledged
problem for epidemiological research into haematological malignancies. Methods: The …